CLINICAL_TRIALS
trial_result
· 2007-01-26
Clinical Trial Update: A Study of LY317615 in Patients With Brain Tumors [Phase 2]
Summary
Phase 2 clinical trial of LY317615 in patients with malignant glioma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Malignant Glioma | Phase 2 | Status: COMPLETED